Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-free EC-MPS Regimen in HCV+ Kidney Transplant Recipients
NCT00284921Phase 3Terminated
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Aug 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of mycophenolate sodium in kidney transplant rejection (2 arms), sponsored by Novartis. Primary endpoint: Hepatic function tests (ALT/AST) at 12 months. Started Apr 2004; status: terminated.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00284921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284921.